We are live on
!
Find out more
TI
Telemetry Investments Portfolio holdings
AUM
$63.3M
Turnover
53.18%
1-Year Est. Return
0.06%
This Fund
S&P 500
This Quarter
Est. Return
+30.32%
1 Year Est. Return
+0.06%
3 Year Est. Return
+77.42%
5 Year Est. Return
+156.79%
10 Year Est. Return
–
AUM
$30M
AUM Growth
-$4.67M
(-13%)
Cap. Flow
-$6.12M
Cap. Flow
% of AUM
-20.38%
Top 10 Holdings %
Top 10 Hldgs %
58.16%
Holding
63
New
11
Increased
7
Reduced
13
Closed
22
Avg Time Held Equity + Options
1.1
years
Top 10 Avg Time Held Equity + Options
0.5
years
Top 20 Avg Time Held Equity + Options
0.4
years
Avg Time Held Equity only
1.1
years
Top 10 Avg Time Held Equity only
0.6
years
Top 20 Avg Time Held Equity only
0.5
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares MSCI Emerging Markets ETF
EEM
|
+$1.07M |
| 2 |
State Street SPDR EURO STOXX 50 ETF
FEZ
|
+$983K |
| 3 |
RARX
Ra Pharmaceuticals, Inc. Common Stock
RARX
|
+$756K |
| 4 |
FIT
Fitbit, Inc. Class A common stock
FIT
|
+$594K |
| 5 |
KEMET Corporation
KEM
|
+$523K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$2.38M |
| 2 |
VSM
Versum Materials, Inc.
VSM
|
+$1.93M |
| 3 |
KDMN
Kadmon Holdings, Inc.
KDMN
|
+$1.58M |
| 4 |
EIGR
Eiger BioPharmaceuticals, Inc.
EIGR
|
+$960K |
| 5 |
MDSO
Medidata Solutions, Inc.
MDSO
|
+$897K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 65.46% |
| 2 | Miscellaneous | 17.14% |
| 3 | Technology | 5.05% |
| 4 | Communication Services | 3.84% |
| 5 | Energy | 2.36% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
WCG
1
DELISTED
Wellcare Health Plans, Inc.
WCG
| $2.87M | 9.57% |
8,700
+600
| +7% | +$180K |
2019 Q2
2 quarters
|
|
|
AGN
2
DELISTED
Allergan plc
AGN
| $2.24M | 7.45% |
11,700
| – | – |
2019 Q3
1 quarter
|
|
|
KDMN
3
DELISTED
Kadmon Holdings, Inc.
KDMN
| $2.09M | 6.95% |
460,788
-430,712
| -48% | -$1.58M |
2016 Q4
12 quarters
|
|
4
DELISTED
Dermira, Inc.
DERM
| $2.06M | 6.85% |
135,559
-2,441
| -2% | -$21.1K |
2019 Q2
2 quarters
|
|
|
EIGR
5
DELISTED
Eiger BioPharmaceuticals, Inc.
EIGR
| $2.02M | 6.74% |
4,528
-2,706
| -37% | -$960K |
2018 Q2
6 quarters
|
|
|
WPX
6
CALL
DELISTED
WPX Energy, Inc.
WPX
| $1.37M | 4.58% |
100,000
| – | – |
2019 Q2
2 quarters
|
|
|
ZSAN
7
DELISTED
Zosano Pharma Corporation
ZSAN
| $1.31M | 4.36% |
24,614
+3,861
| +19% | +$238K |
2018 Q1
7 quarters
|
|
8
Xtant Medical Holdings
XTNT
$44.7M
| $1.21M | 4.02% |
752,915
-18,621
| -2% | -$38.2K |
2018 Q3
5 quarters
|
|
9
DELISTED
Affimed
AFMD
| $1.17M | 3.89% |
42,609
+14,542
| +52% | +$389K |
2015 Q2
18 quarters
|
|
|
10
iShares MSCI Emerging Markets ETF
EEM
$29.8B
| $1.12M | 3.74% |
+25,000
| New | +$1.07M |
2019 Q4
0 quarters
|
|
|
11
State Street SPDR EURO STOXX 50 ETF
FEZ
$4.13B
| $1.02M | 3.4% |
+25,000
| New | +$983K |
2019 Q4
0 quarters
|
|
12
Aclaris Therapeutics
ACRS
$498M
| $833K | 2.78% |
441,000
+226,407
| +106% | +$375K |
2018 Q1
7 quarters
|
|
|
RARX
13
DELISTED
Ra Pharmaceuticals, Inc. Common Stock
RARX
| $803K | 2.68% |
+17,100
| New | +$756K |
2019 Q4
0 quarters
|
|
14
Globalstar
GSAT
$10.7B
| $754K | 2.51% |
96,849
-9,087
| -9% | -$54.9K |
2017 Q3
9 quarters
|
|
|
FIT
15
DELISTED
Fitbit, Inc. Class A common stock
FIT
| $665K | 2.22% |
+101,201
| New | +$594K |
2019 Q4
0 quarters
|
|
16
SPDR Gold Trust
GLD
$139B
| $643K | 2.14% |
4,500
| – | – |
2017 Q3
9 quarters
|
|
|
VRAY
17
DELISTED
ViewRay, Inc.
VRAY
| $629K | 2.1% |
148,951
-2,606
| -2% | -$8.42K |
2017 Q2
10 quarters
|
|
18
ADMA Biologics
ADMA
$2.32B
| $608K | 2.03% |
152,000
+88,000
| +138% | +$384K |
2019 Q2
2 quarters
|
|
|
19
DELISTED
KEMET Corporation
KEM
| $582K | 1.94% |
+21,529
| New | +$523K |
2019 Q4
0 quarters
|
|
20
Rigel Pharmaceuticals
RIGL
$875M
| $483K | 1.61% |
22,550
-200
| -0.9% | -$4.12K |
2014 Q4
20 quarters
|
|
|
MLNX
21
DELISTED
Mellanox Technologies, Ltd.
MLNX
| $444K | 1.48% |
3,789
-2,500
| -40% | -$284K |
2019 Q2
2 quarters
|
|
|
ACIA
22
DELISTED
Acacia Communications Inc
ACIA
| $407K | 1.36% |
6,000
| – | – |
2019 Q3
1 quarter
|
|
23
DELISTED
Sprint Corporation
S
| $399K | 1.33% |
76,500
+2,500
| +3% | +$14.7K |
2018 Q4
4 quarters
|
|
24
DELISTED
Tallgrass Energy, LP Class A Shares
TGE
| $398K | 1.33% |
+18,000
| New | +$345K |
2019 Q4
0 quarters
|
|
|
STML
25
DELISTED
Stemline Therapeutics, Inc.
STML
| $375K | 1.25% |
35,258
-4,742
| -12% | -$47.1K |
2018 Q4
4 quarters
|
|
Similar funds
SF
CAM
SCFS
LCH
SGMPI
HJMC
AI
DFAM
Telemetry Investments's Q4 2019 Portfolio in Review
As of Q4 2019, Telemetry Investments held 63 positions worth $30M, down 13% from $34.7M the previous quarter. Its ten largest holdings account for 58% of the portfolio.
Telemetry Investments withdrew a net $6.12M in Q4 2019, closing 22 positions and reducing 13 holdings. Its most notable exit was Celgene Corp, an estimated $2.38M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 65% of assets, up from 57% a quarter earlier, followed by Miscellaneous and Technology.
Against the trend, Telemetry Investments opened a new position in iShares MSCI Emerging Markets ETF worth $1.12M.
- Telemetry Investments's largest Q4 2019 buy was iShares MSCI Emerging Markets ETF: 25,000 shares worth $1.12M.
- Telemetry Investments added most to Affimed in Q4 2019, an estimated $389K increase.
- Telemetry Investments's biggest Q4 2019 reduction was Kadmon Holdings, Inc., cutting an estimated $1.58M.
- Telemetry Investments fully exited Celgene Corp in Q4 2019, selling an estimated $2.38M.
- Telemetry Investments's ten largest holdings make up 58% of its $30M portfolio in Q4 2019.
- Telemetry Investments opened 11 new positions and closed 22 in Q4 2019.
- Telemetry Investments's portfolio value fell 13% quarter-over-quarter to $30M.
Based on Telemetry Investments's 13F filing for Q4 2019, filed 14 Feb 2020.